Dubuque Bank & Trust’s Emergent Biosolutions EBS Stock Holding History

Dubuque Bank & Trust’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,749	Closed	-$1.84M	–	267
2021 Q3	$1.84M	Hold	36,749	–	–	0.21%	77
2021 Q2	$2.31M	Hold	36,749	–	–	0.26%	72
2021 Q1	$3.41M	Hold	36,749	–	–	0.39%	69
2020 Q4	$3.29M	Hold	36,749	–	–	0.4%	68
2020 Q3	$3.8M	Buy	36,749 +14,282	+64%	+$1.54M	0.56%	62
2020 Q2	$1.78M	Hold	22,467	–	–	0.28%	74
2020 Q1	$1.3M	Buy	+22,467	New	+$1.29M	0.25%	83
2019 Q2	–	Sell	-203	Closed	-$10K	–	293
2019 Q1	$10K	Hold	203	–	–	﹤0.01%	460
2018 Q4	$12K	Sell	203 -204	-50%	-$13.2K	﹤0.01%	412
2018 Q3	$27K	Hold	407	–	–	﹤0.01%	329
2018 Q2	$21K	Hold	407	–	–	﹤0.01%	396
2018 Q1	$21K	Hold	407	–	–	﹤0.01%	428
2017 Q4	$19K	Hold	407	–	–	﹤0.01%	440
2017 Q3	$16K	Hold	407	–	–	﹤0.01%	431
2017 Q2	$14K	Hold	407	–	–	﹤0.01%	433
2017 Q1	$12K	Buy	+407	New	+$12.4K	﹤0.01%	476

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dubuque Bank & Trust's EBS Position: Q4 2021 in Review

Dubuque Bank & Trust sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 36,749 shares — an estimated $1.84M sold.

Dubuque Bank & Trust first reported a position in EBS in Q1 2017 and held it in 16 quarters. The position peaked at $3.8M in Q3 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Dubuque Bank & Trust reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Dubuque Bank & Trust sold 36,749 Emergent Biosolutions shares in Q4 2021, an estimated $1.84M.
Dubuque Bank & Trust first reported a position in Emergent Biosolutions in Q1 2017 and held it in 16 quarters.
Dubuque Bank & Trust's Emergent Biosolutions position peaked at $3.8M in Q3 2020.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Dubuque Bank & Trust's 13F filing for Q4 2021, filed 28 Jan 2022.